The beauty and wellness sector continues to attract strong buyer interest – but the deals generating real competitive tension share a common set of characteristics that go beyond headline revenue.

Over the past 12–24 months, the bar has shifted. Growth still matters, but buyers – strategics and private equity alike – are spending more time on the quality of that growth: how it was generated, how repeatable it is, and whether it can hold under scrutiny.

What they’re looking for comes down to four things. First, customers who come back – high repeat purchase, subscription behaviour, or regular service usage that points to genuine demand rather than paid acquisition. Second, a credible, outcomes-led proposition – products or services that deliver a result and can demonstrate it, whether through clinical evidence, ingredient transparency or professional endorsement. Third, operational depth – supply chain resilience, regulatory readiness, and infrastructure that can support scale. And fourth, a business that works beyond its founder.

The transactions driving attention in the sector – L’Oréal’s acquisition of Medik8, Henkel’s move on Olaplex, e.l.f. Beauty’s acquisition of Rhode – all reflect the same underlying logic: buyers are acquiring durable platforms, not just brands.

For founders, the implication is that preparation matters as much as performance. How a business presents its retention data, articulates its positioning and evidences operational readiness can materially influence both who comes to the table and the outcome.